Clopidogrel as Adjunctive Reperfusion Therapy: Percutaneous Coronary Intervention Subgroup Study - PCI CLARITY


The goal of the study was to evaluate pretreatment with clopidogrel compared with placebo among the subgroup of patients with ST elevation myocardial infarction (STEMI) treated with thrombolytic therapy who underwent percutaneous coronary intervention (PCI) in the CLARITY-TIMI 28 trial.